Preclinical pharmacokinetic evaluation to facilitate repurposing of tyrosine kinase inhibitors nilotinib and imatinib as antiviral agents

Hari Krishna Ananthula; Scott Parker; Erin Touchette; R. Mark Buller; Gopi Patel; Daniel Kalman; Johanna S. Salzer; Nadia Gallardo-Romero; Victoria Olson; Inger K. Damon; Tessa Moir-Savitz; Larry Sallans; Milton H. Werner; Catherine M. Sherwin; Pankaj B. Desai

doi:10.1186/s40360-018-0270-x

Preclinical pharmacokinetic evaluation to facilitate repurposing of tyrosine kinase inhibitors nilotinib and imatinib as antiviral agents

Hari Krishna Ananthula, Scott Parker, Erin Touchette, R. Mark Buller, Gopi Patel, Daniel Kalman, Johanna S. Salzer, Nadia Gallardo-Romero, Victoria Olson, Inger K. Damon, Tessa Moir-Savitz, Larry Sallans, Milton H. Werner, Catherine M. Sherwin, Pankaj B. Desai

Research output: Contribution to journal › Article › peer-review

Original language	English
Article number	80
Journal	BMC Pharmacology and Toxicology
Volume	19
Issue number	1
DOIs	https://doi.org/10.1186/s40360-018-0270-x
State	Published - Dec 4 2018
Externally published	Yes

ASJC Scopus Subject Areas

Pharmacology
Pharmacology (medical)

Keywords

Allometry
Animal rule
Pharmacokinetics
Tyrosine kinase inhibitor

Access to Document

10.1186/s40360-018-0270-x

Cite this

Ananthula, H. K., Parker, S., Touchette, E., Buller, R. M., Patel, G., Kalman, D., Salzer, J. S., Gallardo-Romero, N., Olson, V., Damon, I. K., Moir-Savitz, T., Sallans, L., Werner, M. H., Sherwin, C. M., & Desai, P. B. (2018). Preclinical pharmacokinetic evaluation to facilitate repurposing of tyrosine kinase inhibitors nilotinib and imatinib as antiviral agents. BMC Pharmacology and Toxicology, 19(1), Article 80. https://doi.org/10.1186/s40360-018-0270-x

Ananthula, HK, Parker, S, Touchette, E, Buller, RM, Patel, G, Kalman, D, Salzer, JS, Gallardo-Romero, N, Olson, V, Damon, IK, Moir-Savitz, T, Sallans, L, Werner, MH, Sherwin, CM & Desai, PB 2018, 'Preclinical pharmacokinetic evaluation to facilitate repurposing of tyrosine kinase inhibitors nilotinib and imatinib as antiviral agents', BMC Pharmacology and Toxicology, vol. 19, no. 1, 80. https://doi.org/10.1186/s40360-018-0270-x

@article{ddeab81662ab43ecbf14b8e20214e11e,

title = "Preclinical pharmacokinetic evaluation to facilitate repurposing of tyrosine kinase inhibitors nilotinib and imatinib as antiviral agents",

keywords = "Allometry, Animal rule, Pharmacokinetics, Tyrosine kinase inhibitor",

author = "Ananthula, \{Hari Krishna\} and Scott Parker and Erin Touchette and Buller, \{R. Mark\} and Gopi Patel and Daniel Kalman and Salzer, \{Johanna S.\} and Nadia Gallardo-Romero and Victoria Olson and Damon, \{Inger K.\} and Tessa Moir-Savitz and Larry Sallans and Werner, \{Milton H.\} and Sherwin, \{Catherine M.\} and Desai, \{Pankaj B.\}",

note = "Publisher Copyright: {\textcopyright} 2018 The Author(s).",

year = "2018",

month = dec,

day = "4",

doi = "10.1186/s40360-018-0270-x",

language = "English",

volume = "19",

journal = "BMC Pharmacology and Toxicology",

issn = "2050-6511",

number = "1",

}

TY - JOUR

T1 - Preclinical pharmacokinetic evaluation to facilitate repurposing of tyrosine kinase inhibitors nilotinib and imatinib as antiviral agents

AU - Ananthula, Hari Krishna

AU - Parker, Scott

AU - Touchette, Erin

AU - Buller, R. Mark

AU - Patel, Gopi

AU - Kalman, Daniel

AU - Salzer, Johanna S.

AU - Gallardo-Romero, Nadia

AU - Olson, Victoria

AU - Damon, Inger K.

AU - Moir-Savitz, Tessa

AU - Sallans, Larry

AU - Werner, Milton H.

AU - Sherwin, Catherine M.

AU - Desai, Pankaj B.

PY - 2018/12/4

Y1 - 2018/12/4

KW - Allometry

KW - Animal rule

KW - Pharmacokinetics

KW - Tyrosine kinase inhibitor

UR - https://www.scopus.com/pages/publications/85057738012

UR - https://www.scopus.com/inward/citedby.url?scp=85057738012&partnerID=8YFLogxK

U2 - 10.1186/s40360-018-0270-x

DO - 10.1186/s40360-018-0270-x

M3 - Article

C2 - 30514402

AN - SCOPUS:85057738012

SN - 2050-6511

VL - 19

JO - BMC Pharmacology and Toxicology

JF - BMC Pharmacology and Toxicology

IS - 1

M1 - 80

ER -

Preclinical pharmacokinetic evaluation to facilitate repurposing of tyrosine kinase inhibitors nilotinib and imatinib as antiviral agents

ASJC Scopus Subject Areas

Keywords

Access to Document

Other files and links

Cite this